Outlook PFE / Pfizer Inc.

Although there are several open gaps in Pfizer's chart, I'd like to highlight two of them, as well as the two-times crossed downtrend-line.
Personally I see this as a strong signal that should push the chart even further.
As a logical next step I'd expect the stock to close at least one of the open gaps on the downside and then to rise and close the July '19 gap at USD 41,44.